NEW YORK (GenomeWeb News) – Bioinformatics firm BioDiscovery and the Autism Genetic Resource Exchange today announced a co-marketing agreement that allows AGRE to provide copy number and allelic event data to its researchers through BioDiscovery's Nexus DB platform.

BioDiscovery's platform is for DNA copy number analysis and integrates and processes data from commercial array platforms as well as custom arrays. AGRE, a program of Autism Speaks, collects and houses genetic and phenotypic data on more than 1,300 families with autism.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease. 

Jun
23
Sponsored by
PerkinElmer

This webinar will demonstrate how automated liquid handling workstations can reduce bottlenecks in library preparation for next-generation sequencing, enabling scientific advances in genomics research that were not possible five years ago.